About Synakis
Synakis has created a vitreous substitute to transform the treatment of retinal detachment which use vitreous substitutes.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Seed
Global Headquarters
Toronto, Canada
Tracked Since
Oct 2, 2026
Web & Domain Identity
Official Website
synakis.ca
Domain Registered Date
Dec 3, 2021
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Seed announced
- Milestone
Website domain registered
synakis.ca
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for Synakis.
Funding History
Seed
· May 11, 2026
Undisclosed
Pre-Seed
· Undisclosed
$1,824,602 synakis.ca
Founders & Leadership
Alexander Baker
Founder
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026